Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.

Autor: Garg, Naveen¹ (AUTHOR), Tellier, Guy² (AUTHOR), Vale, Noah³ (AUTHOR), Kluge, Jon⁴ (AUTHOR), Portman, Jonathan L.⁴ (AUTHOR), Markowska, Anna⁴ (AUTHOR), Tussey, Lynda⁵ (AUTHOR) lynda@vaxess.com

Publikováno v: PLoS ONE. 6/6/2024, Vol. 19 Issue 6, p1-23. 23p.

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.

Autor: Tinoco JC; Hospital General de Durango, Durango, Mexico. Electronic address: jctinoco@prodigy.net.mx., Pavia-Ruz N; Universidad Nacional Autonoma de Mexico, Mexico City, Mexico., Cruz-Valdez A; National Institute of Public Health, Cuernavaca, Morelos, Mexico., Aranza Doniz C; Secretaria de Salud del Estado de Mexico, Zumpango, Mexico., Chandrasekaran V; GlaxoSmithKline Vaccines, King of Prussia, PA, USA., Dewé W; GlaxoSmithKline Vaccines, Rixensart, Belgium., Liu A; GlaxoSmithKline Vaccines, King of Prussia, PA, USA., Innis BL; GlaxoSmithKline Vaccines, King of Prussia, PA, USA., Jain VK; GlaxoSmithKline Vaccines, King of Prussia, PA, USA.

Publikováno v: Vaccine [Vaccine] 2014 Mar 14; Vol. 32 (13), pp. 1480-7. Date of Electronic Publication: 2014 Jan 28.

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.

Autor: Villanueva, Paola^1,2,3,4 (AUTHOR), Wadia, Ushma⁵ (AUTHOR), Crawford, Nigel W.^1,2,4,6 (AUTHOR), Messina, Nicole L.^1,2 (AUTHOR), Kollmann, Tobias R.⁵ (AUTHOR), Lucas, Michaela^7,8,9,10 (AUTHOR), Manning, Laurens^5,7,11 (AUTHOR), Richmond, Peter^5,7,9 (AUTHOR), Pittet, Laure F.^1,2,3 (AUTHOR), Curtis, Nigel^1,2,3 (AUTHOR) nigel.curtis@rch.org.au

Publikováno v: PLoS ONE. 6/3/2022, Vol. 17 Issue 6, p1-13. 13p.

Carencias y variabilidad en la calidad de la atención a neonatos hospitalizados en México. Estudio transversal en 28 hospitales públicos.

Autor: Jesús Saturno-Hernández, Pedro¹ sergio.flores@insp.mx, Poblano-Verástegui, Ofelia¹, Flores-Hernández, Sergio¹, Martínez-Nicolás, Ismael¹, Vieyra-Romero, Waldo¹, Elizabeth Halley-Castillo, María²

Publikováno v: Salud Pública de México. Mar/Apr2021, Vol. 63 Issue 2, p180-189. 10p.

Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate—Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Autor: Pillet, Stéphane^1,2, Couillard, Julie¹, Trépanier, Sonia¹, Poulin, Jean-François³, Yassine-Diab, Bader³, Guy, Bruno⁴, Ward, Brian J.^1,2, Landry, Nathalie¹ landryn@medicago.com

Publikováno v: PLoS ONE. 6/5/2019, p1-26. 26p.